SPYRE THERAPEUTICS, INC. (SYRE) scores 36 out of 100 on boothcheck's 11-model valuation framework. Verdict: Bad The estimated fair value is $0.00. Quantitative score: 38/100. Qualitative score: 60/100.
Analysis includes bear, base, and bull fair value targets using DCF, Graham, regression, and 8 other valuation models.